INNOVATIVE RESEARCH FUNDING ALLIANCE SPEND MONEY ON PHARMA PROJECT
October 1st, 2012
BY KEITH NUTHALL
A CONSORTIUM involving two European biotech companies has secured a Euro EUR4.55 million grant from the EU's Eurostars funding programme to develop ground-breaking anti-infection medicine. Eurostars is a joint programme between EU research network EUREKA and the European Commission, and the first European research funding programme dedicated to small-and-medium-sized enterprises (SMEs). This award will be used by the KLEBISCURE research project, led by Vienna-based start-up Arsanis. Other consortium members include Germany's GATC Biotech, the ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.